Hot Stocks to Watch: Editas Medicine Inc. (NASDAQ:EDIT), UBS Group AG (NYSE:UBS)

Editas Medicine Inc. (NASDAQ:EDIT)

The shares of Editas Medicine Inc. (NASDAQ:EDIT) started off the last trading session with the price of $40.25 while closing the day with the price of $41.42. The shares of Editas Medicine Inc. (NASDAQ:EDIT) Fell -0.84% with the Gain of 1.17 points.

The shares of Editas Medicine Inc. (NASDAQ:EDIT) traded with the day volume of 1.7 Million shares whereas its average trading volume is 1.67 Million.

While analyzing the past performance of the stock we can see that the shares of Editas Medicine Inc. (NASDAQ:EDIT) Gain 7.75% in the last week while rising 22.94% in the last month. Past quarter performance shows the green light with 65.95%. The semi-annual and annual performance shows 107.31% and 66.28% respectively.

Some critical values of the shares of Editas Medicine Inc. (NASDAQ:EDIT) to be discussed here are: the beta which shows the value at 0 while Average True Range of Editas Medicine Inc. (NASDAQ:EDIT) demonstrate the value at 2.85. The weekly and monthly volatility of the shares of Editas Medicine Inc. (NASDAQ:EDIT) are indicated at 8.73% and 7.31%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 62.02.

While studying the financial position of the shares of Editas Medicine Inc. (NASDAQ:EDIT), we can see that the Market capitalization of the company is at 1.82 Billion. The shares outstanding for the company is 44.06 Million and the shares float stands at 38.52 Million. The income of the company stand at -120300000 while the sales stand at 13.7 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -2.99, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 133.21, the Return on Asset ROA stood at -0.326 and the Return on Equity ROE depicted at -0.619 while Return on Investment ROI is at -0.482.


UBS Group AG (NYSE:UBS)

UBS Group AG (NYSE:UBS) started its previous trading session at $18.52 and closed at $18.23 showing a Fell of -1.73 Percent.

The Company traded with an average Volume of 2.52 Million whereas, its Day Volume stood at 1.7 Million.

Looking at the performance of the stock, UBS Group AG (NYSE:UBS) Loss -1.88% in the last week in its shares price and -1.99% in the last month. Quarterly performance shows a green of 4.29 Percent while Semi-Annual and Annual performances shows a 10.62 and 14.44 percent respectively.

Beta for UBS Group AG (NYSE:UBS) stands at 1.23 while the ATR (average true range) is at 0.34. The Stock’s Weekly and Monthly Volatility is 1.12% and 1.38% respectively showing a RSI value of 36.81.

While studying the financial position of the shares of UBS Group AG (NYSE:UBS), we can see that the Market capitalization of the company is at 70.26 Billion. The shares outstanding for the company is 3.85 Billion and the shares float stands at 3.85 Billion.

The Company generated an income of 1.23 Billion and the sales of 14.93 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.3 a share. P/E (price to earnings) and P/S (price to sales) values are 60.56 and 4.71 respectively.

The Return on Assets stands at 0.001, ROE shows a value of 0.02 and ROI for UBS Group AG (NYSE:UBS) is 0.009 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment